IMM-1-104 combined with mGnP shows promising efficacy and tolerability in first-line pancreatic cancer, with a 43% ORR and 86% DCR among seven patients. IMM-1-104 demonstrated target lesion shrinkage ...

A look at the shareholders of Immutep Limited (ASX:IMM) can tell us which group is most powerful. With 51% stake, institutions possess the maximum shares in the company. That is, the group stands to ...

COLOGNE, Germany — With the German furniture industry struggling for business, the organizers of the IMM Cologne 2025, set for Jan. 12-16, said the tradeshow is “taking a time-out in January,” ...

Seoul-based IMM Investment, an early backer of Krafton and an investor in roughly half of South Korea’s unicorns, has marked the first close of the India fund and has hired former Legend Capital ...

About IMM The Institute for Molecular Medicine (IMM) is a non-profit research organization dedicated to understanding, preventing, and curing chronic human diseases, with a focus on neurodegeneration.

If you love investing in stocks you're bound to buy some losers. But long term Immutep Limited (ASX:IMM) shareholders have had a particularly rough ride in the last three year. Sadly for them, the ...